The purpose of this study is to assess the effectiveness of radiofrequency ablation (RFA) of the posterior nasal nerve (PNN) in chronic rhinitis (CR) patients by comparing patient reflective total nasal symptom score (rTNSS) and nasal obstruction symptom evaluation (NOSE) , peak nasal inspiratory flow (PNIF) , and levels of Type 2 cytokines pre- and post-procedure.
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Nasal Congestion as Assessed by the Peak Nasal Inspiratory Flow (PNIF)
Timeframe: Baseline
Nasal Congestion as Assessed by the Peak Nasal Inspiratory Flow (PNIF)
Timeframe: 4 weeks post intervention
Nasal Congestion as Assessed by the Peak Nasal Inspiratory Flow (PNIF)
Timeframe: 12 weeks post intervention
Interleukin-10 (IL-10)
Timeframe: Baseline
Interleukin-22 (IL-22)
Timeframe: Baseline
Interleukin-10 (IL-10)
Timeframe: 12 weeks post intervention
Interleukin-22 (IL-22)
Timeframe: 12 weeks post intervention